The Pledge Wall

Head of Alzheimer’s Disease, Europe, Canada and Partner Markets, Biogen

#WeWontRest until we succeed in making meaningful improvements to the lives of people impacted by Alzheimer’s disease, including their families.

Annabel Cowper

Director of Corporate Affairs, Biogen

#WeWontRest until we can change the course of the disease for people living with Alzheimer’s disease and give them and their families a promising future.

Alessandro Marcuzzi, EMEA

Head of Alzheimer’s Disease, Europe, Canada & Partner Markets, Biogen

#WeWontRest in our mission to bring new hope to patients affected by devastating diseases with a high unmet medical need

Sean Knox, Switzerland

Medical Lead, EU+ Alzheimer’s Disease - Global Medical Affairs Neurology, Biogen

#WeWontRest until we have succeeded in translating the world leading research in Alzheimer’s disease into medical innovations that tackle the global unmet need in the area of AD

Samantha Budd Haeberlein, USA

Vice President, Clinical Development, Biogen

#WeWontRest until we succeed in delivering a disease modifying treatment. We really hope we can help meaningfully change the course of Alzheimer’s Disease and significantly improve the lives of Alzheimer’s patients and their families.

Frederic Clais, Belgium

Country Manager Belgium/Luxembourg, Lilly

Alzheimer’s: forgetting what was so obvious before. We continue to strive to find a treatment that modifies the course of the disease and #WeWontRest until we do so.